Medicus Pharma (MDCXW) Shares Outstanding (2023 - 2025)
Medicus Pharma (MDCXW) reported Shares Outstanding of $25.2 million for Q4 2025, up 113.06% on a YoY basis from $11.8 million in Q4 2024, and up 20.05% quarter-over-quarter from $21.0 million in Q3 2025.
Medicus Pharma (MDCXW) Shares Outstanding (2023 - 2025) Analysis & Trends
Medicus Pharma has reported Shares Outstanding for 3 years, with the latest figure at $25.2 million in Q4 2025.
- For the quarter ending Q4 2025, Shares Outstanding rose 113.06% year-over-year to $25.2 million; the trailing twelve-month figure through Dec 2025 stood at $25.2 million (up 113.06% YoY), and the FY2025 full-year result was $25.2 million, up 113.06% from the prior year.
- Shares Outstanding for Q4 2025 stood at $25.2 million, up from $21.0 million in the prior quarter.
- The five-year high for Shares Outstanding was $25.2 million in Q4 2025, with the low at $8.1 million in Q4 2023.
- Historically, Shares Outstanding has averaged $14.4 million across 3 years, with a median of $11.8 million in 2024.
- Annual changes were most pronounced in 2024 — Shares Outstanding surged 46.31% — and 2025, when it surged 113.06%.
- Medicus Pharma's Shares Outstanding stood at $8.1 million in 2023, then surged by 46.31% to $11.8 million in 2024, then jumped by 113.06% to $25.2 million in 2025.
- The last three Shares Outstanding figures came in at $25.2 million (Q4 2025), $21.0 million (Q3 2025), and $15.9 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 93,699,046.73 Bn | 93,699,041.77 Bn | 7.76 Bn | - |
| 2 | Eli Lilly | 1,012.06 Bn | 1,006.77 Bn | 16.22 Bn | 943.50 Mn |
| 3 | Johnson & Johnson | 560.67 Bn | 538.62 Bn | 15.96 Bn | 3.12 Bn |
| 4 | AbbVie | 402.20 Bn | 392.85 Bn | 10.78 Bn | 1.77 Bn |
| 5 | Merck | 298.59 Bn | 292.94 Bn | 12.09 Bn | 3.58 Bn |
| 6 | Amgen | 188.77 Bn | 176.74 Bn | 5.87 Bn | 539.70 Mn |
| 7 | Gilead Sciences | 160.22 Bn | 152.49 Bn | 5.52 Bn | 1.24 Bn |
| 8 | Pfizer | 148.19 Bn | 135.42 Bn | -1.21 Bn | 9.64 Bn |
| 9 | Bristol Myers Squibb | 116.72 Bn | 106.26 Bn | 8.07 Bn | 2.92 Bn |
| 10 | Medicus Pharma | - | - | - | 25.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 25.18 Mn |
| Dec 31, 2025 | 25.18 Mn |
| Dec 31, 2025 | 25.18 Mn |
| Dec 31, 2025 | 25.18 Mn |
| Dec 31, 2025 | 25.18 Mn |
| Dec 31, 2025 | 25.18 Mn |
| Dec 31, 2025 | 25.18 Mn |
| Dec 31, 2025 | 25.18 Mn |
| Sep 30, 2025 | 20.97 Mn |
| Sep 30, 2025 | 20.97 Mn |
| Sep 30, 2025 | 20.97 Mn |
| Sep 30, 2025 | 20.97 Mn |
| Sep 30, 2025 | 20.97 Mn |
| Sep 30, 2025 | 20.97 Mn |
| Sep 30, 2025 | 20.97 Mn |
| Sep 30, 2025 | 20.97 Mn |
| Jun 30, 2025 | 15.94 Mn |
| Jun 30, 2025 | 15.94 Mn |
| Jun 30, 2025 | 15.94 Mn |
| Jun 30, 2025 | 15.94 Mn |